Delivery Order SPE2DP18D0006-SPE2DP19F0370
Award Date 10/17/18
Potential Completion Date 10/19/18
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $9,033,542.56, was issued by the Defense Department's Medical Supply Chain agency to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of influenza virus vaccines. The contract has a firm fixed price structure and an ultimate completion date of October 17, 2016. It is not designated as a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This is a delivery order contract (SPE2DP19F0724) awarded by the U.S. Department of Defense (DoD) Medical Supply Chain to Glaxosmithkline, LLC for the provision of influenza virus vaccine. The $3,582 firm fixed price contract has a completion date of November 30, 2018 and does not utilize a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has provided a range of vaccines and antiviral medications to federal agencies through multiple indefinite delivery...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- This federal contract award, SPE2DP15D0006|0008, was issued by the U.S. Defense Logistics Agency (DLA) to the prime contractor GlaxoSmithKline, LLC for the delivery of influenza virus vaccines. The $100,660.00 firm fixed price contract has a completion date of November 30, 2015 and does not have a set-aside designation. GlaxoSmithKline is a global pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contracts...
- This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
- This federal contract award, with ID SPE2DP16D0006|0005, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The $282,870.56 firm fixed price delivery order has an ultimate completion date of November 30, 2016 and does not have a set-aside designation. Glaxosmithkline, LLC is a prime contractor that has received various federal contract and grant awards to supply...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), which is part of the U.S. Department of Veterans Affairs (VA), to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of influenza vaccines. The contract has a ceiling value of $264,525.30 and is a firm fixed price delivery order with no set-aside designation. The contract supports flu prevention and immunization programs for the VA. Glaxosmithkline, LLC has also received other...